Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Scott M. Coiante currently holds 320,473 shares of Aprea Therapeutics, Inc. (APRE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott M. Coiante has been a net buyer of APRE stock. They have purchased $37.5K and sold $0 worth of shares.
Scott M. Coiante's most recent insider trade was on Feb 28, 2026, when they sold 160,237 shares at $0.00 per share.
Scott M. Coiante serves as Executive at Aprea Therapeutics, Inc. (APRE). They have executed 18 insider transactions totaling $37.5K over their tenure at the company.
Scott M. Coiante holds the position of Executive at Aprea Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Scott M. Coiante has shown a buying trading pattern, with $37.5K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Scott M. Coiante was on Feb 28, 2026, when they sold $80.7K worth of LXRX shares. This transaction involved 54,881 shares at $1.47 per share.
Scott M. Coiante currently owns 320,473 shares of Aprea Therapeutics, Inc. (APRE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Scott M. Coiante's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Scott M. Coiante has 18 Form 4 filings on record as an insider at Aprea Therapeutics, Inc..
Set alerts for Scott M. Coiante and 40,000+ other insiders.